Results 21 to 30 of about 40,516 (197)

QALYs loss due to premature mortality and QALYs associated with morbidity a year into the COVID-19 pandemic.

, 2023
QALYs loss due to premature mortality and QALYs associated with morbidity a year into the COVID-19 pandemic.
Raymond Duch (11766945), Matias Fuentes Becerra (15208299), Jack Pollard (463829), Philip M. Clarke (9454722), Laurence S. J. Roope (8749818), Andrew Lloyd (299166), Mara Violato (151306)   +6 more
core   +1 more source

Characterizing QALYs under a General Rank Dependent Utility Model [PDF]

, 1997
This paper provides a characterization of QALYs, the most important outcome measure in medical decision making, in the context of a general rank dependent utility model.
Quiggin, J. (John), Bleichrodt, H. (Han)
core   +2 more sources

Estimated Impact of Deemed Consent Legislation for Organ Donation on Individuals With Kidney Failure: A Dynamic Decision Analytic Model

Canadian Journal of Kidney Health and Disease, 2022
Background: There is little data modeling the impact of deemed consent legislation (eligible individuals who do not register their decision to decline to be a donor are presumed to consent after death) on outcomes for individuals with kidney failure ...
Koto P., Vinson A. J., Kiberd B. A., Beed S., Krmpotic K., Dirk J., Weiss M. J., Karthik K. Tennankore   +7 more
doaj   +1 more source

ICER, ISPOR AND QALYs: A Tale of Imaginary Worlds

INNOVATIONS in Pharmacy, 2019
Previous commentaries in the Formulary Evaluation section of INNOVATIONS in Pharmacy have pointed to the lack of credibility in modeled claims for cost-effectiveness and associated recommendations for pricing by the Institute for Clinical and Economic ...
Paul Langley
doaj   +1 more source

QALYs: The Math Doesn’t Work [PDF]

, 2023
The quality-adjusted life-year (QALY) is a metric widely used when assessing the cost-effectiveness of drugs and other health interventions. The assessments are used in the development of recommendations for pricing, formulary placement decisions, and ...
Sirimon O'Charoen, Angela Dobes, Tia G. Sawhney   +2 more
core   +1 more source

Problems and solutions in calculating quality-adjusted life years (QALYs)

Health and Quality of Life Outcomes, 2003
The quality-adjusted life-year (QALY) is a measure of the value of health outcomes. Since health is a function of length of life and quality of life, the QALY was developed as an attempt to combine the value of these attributes into a single index number.
Sacristán José A, Prieto Luis
doaj   +1 more source

Cost-effectiveness analysis in primary care research: A practical guide for early-career researchers

African Journal of Primary Health Care & Family Medicine
Cost-effectiveness analysis (CEA) is an important tool for guiding decisions on resource allocation in primary health care (PHC), particularly in low- and middle-income countries that face constrained budgets and competing health priorities.
Akim T. Lukwa, Klaus B. von Pressentin, Robert Mash   +2 more
doaj   +1 more source

Investment case for two-year post university speciality training in family medicine in Tajikistan: how much is needed for continuing and scaling up the improved education of family doctors?

BMC Health Services Research, 2020
Background A new two-year Post University Specialty Training (PUST) programme in family medicine was introduced to improve the quality of postgraduate speciality medical education in Tajikistan.
Jari Kempers, Leah F. Bohle, Alexandra Topa, Greta Ross, Zukhra Kasymova, Shakhlo Yarbaeva, Cristina Rotaru, Helen Prytherch   +7 more
doaj   +1 more source

Calculating QALYs, comparing QALY and DALY calculations [PDF]

Health Policy and Planning, 2006
Quality-adjusted life years (QALYs) have been used in the assessment of health interventions for three decades. The popularity of the QALY approach has been constantly increasing, although the debate on its theoretical underpinnings and practical implications is still ongoing.
openaire   +2 more sources

Health losses (QALYs).

, 2021
R and the efficacy against transmission vary and are labelled on the side (R) and the top (efficacy). Community infections refers to QALYs lost from acute COVID infections that do not result in hospitalization.
Paul Tupper (11098871), Erin Kirwin (7547093), Christopher McCabe (206680), Nicola Mulberry (7376975), Caroline Colijn (164960)   +4 more
core   +1 more source